These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The pulmonary fibrosis-associated MUC5B promoter polymorphism does not influence the development of interstitial pneumonia in systemic sclerosis. Peljto AL; Steele MP; Fingerlin TE; Hinchcliff ME; Murphy E; Podlusky S; Carns M; Schwarz M; Varga J; Schwartz DA Chest; 2012 Dec; 142(6):1584-1588. PubMed ID: 22576636 [TBL] [Abstract][Full Text] [Related]
5. Mucin 5B promoter polymorphism is associated with susceptibility to interstitial lung diseases in Chinese males. Wang C; Zhuang Y; Guo W; Cao L; Zhang H; Xu L; Fan Y; Zhang D; Wang Y PLoS One; 2014; 9(8):e104919. PubMed ID: 25121989 [TBL] [Abstract][Full Text] [Related]
6. Interaction between the promoter Stock CJ; Conti C; Montero-Fernandez Á; Caramori G; Molyneaux PL; George PM; Kokosi M; Kouranos V; Maher TM; Chua F; Rice A; Denton CP; Nicholson AG; Wells A; Sestini P; Renzoni EA Thorax; 2020 Oct; 75(10):901-903. PubMed ID: 32580994 [TBL] [Abstract][Full Text] [Related]
7. MUC5B promoter polymorphism and interstitial lung abnormalities. Hunninghake GM; Hatabu H; Okajima Y; Gao W; Dupuis J; Latourelle JC; Nishino M; Araki T; Zazueta OE; Kurugol S; Ross JC; San José Estépar R; Murphy E; Steele MP; Loyd JE; Schwarz MI; Fingerlin TE; Rosas IO; Washko GR; O'Connor GT; Schwartz DA N Engl J Med; 2013 Jun; 368(23):2192-200. PubMed ID: 23692170 [TBL] [Abstract][Full Text] [Related]
8. The MUC5B Promoter Polymorphism is Not Associated With Non-ILD Chronic Respiratory Diseases or Post-transplant Outcome. Goos T; Verleden SE; De Sadeleer LJ; Van Herck A; Sacreas A; Vanstapel A; Kaes J; Geudens V; Aelbrecht C; Ruttens D; Lambrechts D; Vermeer S; Ceulemans LJ; Van Raemdonck DE; Godinas L; Yserbyt J; Vanaudenaerde BM; Verleden GM; Vos R; Wuyts WA Transpl Int; 2022; 35():10159. PubMed ID: 35651878 [TBL] [Abstract][Full Text] [Related]
9. Prospective Identification of Subclinical Interstitial Lung Disease in a Rheumatoid Arthritis Cohort Is Associated with the Matson SM; Deane KD; Peljto AL; Bang TJ; Sachs PB; Walts AD; Collora C; Ye S; Demoruelle MK; Humphries SM; Schwartz DA; Lee JS Am J Respir Crit Care Med; 2022 Feb; 205(4):473-476. PubMed ID: 34874815 [No Abstract] [Full Text] [Related]
12. The Putman RK; Gudmundsson G; Araki T; Nishino M; Sigurdsson S; Gudmundsson EF; Eiríksdottír G; Aspelund T; Ross JC; San José Estépar R; Miller ER; Yamada Y; Yanagawa M; Tomiyama N; Launer LJ; Harris TB; El-Chemaly S; Raby BA; Cho MH; Rosas IO; Washko GR; Schwartz DA; Silverman EK; Gudnason V; Hatabu H; Hunninghake GM Eur Respir J; 2017 Sep; 50(3):. PubMed ID: 28893869 [TBL] [Abstract][Full Text] [Related]
13. Exploration of the MUC5B promoter variant and ILD risk in patients with autoimmune myositis. Johnson C; Rosen P; Lloyd T; Horton M; Christopher-Stine L; Oddis CV; Mammen AL; Danoff SK Respir Med; 2017 Sep; 130():52-54. PubMed ID: 29206633 [TBL] [Abstract][Full Text] [Related]
14. Clinical and Genetic Associations of Objectively Identified Interstitial Changes in Smokers. Ash SY; Harmouche R; Putman RK; Ross JC; Diaz AA; Hunninghake GM; Onieva Onieva J; Martinez FJ; Choi AM; Lynch DA; Hatabu H; Rosas IO; San Jose Estepar R; Washko GR; Chest; 2017 Oct; 152(4):780-791. PubMed ID: 28506611 [TBL] [Abstract][Full Text] [Related]
15. Towards clinical significance of the Sparks JA Ann Rheum Dis; 2021 Dec; 80(12):1503-1504. PubMed ID: 34344705 [No Abstract] [Full Text] [Related]
16. Integrating Genomics Into Management of Fibrotic Interstitial Lung Disease. Adegunsoye A; Vij R; Noth I Chest; 2019 May; 155(5):1026-1040. PubMed ID: 30660786 [TBL] [Abstract][Full Text] [Related]
17. Lifetime risk of rheumatoid arthritis-associated interstitial lung disease in Palomäki A; ; Palotie A; Koskela J; Eklund KK; Pirinen M; ; Ripatti S; Laitinen T; Mars N Ann Rheum Dis; 2021 Dec; 80(12):1530-1536. PubMed ID: 34344703 [TBL] [Abstract][Full Text] [Related]
18. Association between acute respiratory disease events and the Ash SY; Harmouche R; Putman RK; Ross JC; Martinez FJ; Choi AM; Bowler RP; Regan EA; Curtis JL; Han MK; Boucher RC; O'Neal WK; Hatabu H; Lynch DA; Rosas IO; Hunninghake GM; San Jose Estepar R; Washko GR; Thorax; 2018 Nov; 73(11):1071-1074. PubMed ID: 29440587 [TBL] [Abstract][Full Text] [Related]
19. Bedside to gene and back in idiopathic pulmonary fibrosis. Cookson WO; Moffatt MF N Engl J Med; 2013 Jun; 368(23):2228-30. PubMed ID: 23692168 [No Abstract] [Full Text] [Related]
20. Effect of Muc5b promoter polymorphism on disease predisposition and survival in idiopathic interstitial pneumonias. van der Vis JJ; Snetselaar R; Kazemier KM; ten Klooster L; Grutters JC; van Moorsel CH Respirology; 2016 May; 21(4):712-7. PubMed ID: 26699835 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]